JENNE KYLE (Chief Commercial Officer) reported 1 transaction at AKCEA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
−52.01K
Price / share
$18.15
Trade value
$944.02K
% of position
Net shares
−52.01K
Net value
-$944.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/12/2020 | U · U | −52.01K | $18.15 | $944.02K | New position | 52.01K | 0.00 |
| Total | −52.01K | -$944.02K | ||||||
Stock Option (right to buy)
Common Stock
143.37K shares
Shares
−143.37K
Strike price
12.21
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
32.75K shares
Shares
−32.75K
Strike price
12.21
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
299.00 shares
Shares
−299.00
Strike price
17.38
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
13.70K shares
Shares
−13.70K
Strike price
17.38
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
34.20K shares
Shares
−34.20K
Strike price
12.76
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock143.37K shares | 10/12/2020 | D · Disposition | −143.37K | 12.21 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock32.75K shares | 10/12/2020 | D · Disposition | −32.75K | 12.21 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock299.00 shares | 10/12/2020 | D · Disposition | −299.00 | 17.38 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock13.70K shares | 10/12/2020 | D · Disposition | −13.70K | 17.38 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock34.20K shares | 10/12/2020 | D · Disposition | −34.20K | 12.76 | — | 0.00 |